"10.1371_journal.pone.0146114","plos one","2016-01-06T00:00:00Z","Emilia Ottosson-Laakso; Tiinamaija Tuomi; Björn Forsén; Monika Gullström; Per-Henrik Groop; Leif Groop; Petter Vikman","Diabetes and Endocrinology, Department of Clinical Sciences, Lund University, Malmö, Sweden; Folkhälsan Institute of Genetics, Folkhälsan Research Centre, Biomedicum, Helsinki, Finland; Research Program Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland; Närpes Health Care Center, Närpes, Finland; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland","Conceived and designed the experiments: TT P-HG LG PV. Performed the experiments: EO-L MG BF. Analyzed the data: EO-L PV. Contributed reagents/materials/analysis tools: BF P-HG LG. Wrote the paper: EO-L TT P-HG LG PV.","P-H Groop has received lecture honorariums from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Genzyme, Medscape, MSD, Novartis, Novo Nordisk and Sanofi. P-H Groop is an advisory board member of AbbVie, Boeringer Ingelheim, Eli Lilly, Janssen, Medscape and Novartis. P-H Groop has received investigator-initiated research grants from Eli Lilly and Roche. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Emilia Ottosson-Laakso","EOL",7,TRUE,4,3,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
